SKB565

· Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SKB565, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: SKB565 for Injection in Advanced Solid Tumors [Phase 1, Phase 2]